Key Points
- On March 10, Alignment Healthcare CEO John Kao sold 180,000 shares at an average price of $18.19 for about $3.274 million, trimming his stake by 6.79% to 2,472,641 shares (worth roughly $44.98 million).
- Alignment reported Q results with EPS of ($0.05) that beat estimates by $0.10 and revenue of $1.01 billion (up 44.4% year‑over‑year); the stock trades near $18 and has a market cap of about $3.7 billion.
- Analyst sentiment is generally positive with a consensus rating of Moderate Buy and an average target of $24.56, and several firms (JPMorgan, Piper Sandler, UBS, Robert W. Baird) recently raised price targets.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 180,000 shares of the stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $18.19, for a total value of $3,274,200.00. Following the transaction, the chief executive officer directly owned 2,472,641 shares of the company's stock, valued at approximately $44,977,339.79. The trade was a 6.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Alignment Healthcare Stock Down 0.7%
Shares of ALHC stock opened at $18.10 on Wednesday. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. The business's fifty day moving average is $20.91 and its 200-day moving average is $18.73. The stock has a market cap of $3.70 billion, a PE ratio of -1,808.19, a price-to-earnings-growth ratio of 2.67 and a beta of 1.18.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.10. The business had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The company's revenue was up 44.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.16) earnings per share. Equities analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an "overweight" rating in a research note on Thursday, February 5th. Weiss Ratings reissued a "sell (d-)" rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a report on Friday, January 30th. Piper Sandler lifted their price target on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 6th. Finally, UBS Group upped their price target on Alignment Healthcare from $18.00 to $21.00 and gave the company a "neutral" rating in a report on Wednesday, January 14th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $24.56.
Read Our Latest Report on Alignment Healthcare
Institutional Trading of Alignment Healthcare
Several institutional investors and hedge funds have recently bought and sold shares of ALHC. Teacher Retirement System of Texas raised its holdings in shares of Alignment Healthcare by 85.8% during the third quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company's stock valued at $1,794,000 after acquiring an additional 47,472 shares during the period. Y Intercept Hong Kong Ltd acquired a new position in Alignment Healthcare in the 3rd quarter worth approximately $3,499,000. Inspire Investing LLC acquired a new stake in Alignment Healthcare during the 3rd quarter valued at $1,129,000. Ameritas Investment Partners Inc. grew its holdings in shares of Alignment Healthcare by 32.9% during the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company's stock valued at $182,000 after buying an additional 3,225 shares in the last quarter. Finally, Picton Mahoney Asset Management acquired a new position in Alignment Healthcare during the third quarter valued at $6,873,000. Institutional investors and hedge funds own 86.19% of the company's stock.
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
